• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AXONICS MODULATION TECHNOLOGIES, INC. AXONICS; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AXONICS MODULATION TECHNOLOGIES, INC. AXONICS; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 1101
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Urinary Tract Infection (2120); Discomfort (2330); Urinary Incontinence (4572)
Date of Event 01/21/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Block d2b: product code: additional product code qon.Block g4: premarket / 510(k) #: additional premarket / 510(k) # p190006.Udi for concomitant product, tined lead: (b)(4).Block h11: investigation details: the device was not returned for analysis; therefore, a technical analysis could not be performed.Good faith effort attempts were made to try and retrieve the device; however, the product was not returned.It was confirmed the device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.A risk review was completed and confirmed that the event of discomfort, urinary incontinence, urinary tract infection, and pain was defined in the product risk documentation.This event type has been accounted for during analysis to support acceptable risk benefit for the product.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Event or Problem Description
It was reported the patient turned off their device due to pain.The patient stated they have chronic cystitis and makes them frequently urinate.The patient also had frequent urinary tract infections and pain in their rectum.The physician had the patient turn off their stimulation and the patient said the pain subsided but still present.Additionally, the patient had surgery to explant their neurostimulator and tined lead on (b)(6) 2026.The physician recommended the removal due to the discomfort.Per the patient, they are doing better now and there is no more pain around the site.
 
Event or Problem Description
It was reported the patient turned off their device due to pain.The patient stated they have chronic cystitis and makes them frequently urinate.The patient also had frequent urinary tract infections and pain in their rectum.The physician had the patient turn off their stimulation and the patient said the pain subsided but still present.Additionally, the patient had surgery to explant their neurostimulator and tined lead on (b)(6) 2026.The physician recommended the removal due to the discomfort.Per the patient, they are doing better now and there is no more pain around the site.
 
Additional Manufacturer Narrative
Block d2b: product code: additional product code qon.Block d10: model number/catalog number: 1201.Serial number: (b)(6).Batch/lot number: al1h721992.Model/catalog description: tined lead.Unique identifier (udi) #: (b)(4).Block g4: premarket / 510(k) #: additional premarket / 510(k) # p190006.Block h11: investigation details: the device was not returned for analysis; therefore, a technical analysis could not be performed.Good faith effort attempts were made to try and retrieve the device; however, the product was not returned.It was confirmed the device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.A risk review was completed and confirmed that the event of discomfort, urinary incontinence, urinary tract infection, and pain was defined in the product risk documentation.This event type has been accounted for during analysis to support acceptable risk benefit for the product.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.Correction: block h11: udi, tined lead model number and catalog description.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXONICS
Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
AXONICS MODULATION TECHNOLOGIES, INC.
15515 sand canyon ave
irvine CA 92618
Manufacturer (Section G)
AXONICS INC
26 technology dr
irvine CA 92618
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key24693985
Report Number2124215-2026-16474
Device Sequence Number10557760
Product Code EZW
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P180046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/05/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date03/28/2025
Device Model Number1101
Device Catalogue Number1101
Device Lot NumberAX1H181561
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/27/2026
Supplement Date Received by Manufacturer04/16/2026
Initial Report FDA Received Date03/25/2026
Supplement Report FDA Received Date05/05/2026
Date Device Manufactured03/28/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age63 YR
Patient SexFemale
-
-